“Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s63. Accessed May 22, 2026. https://skin.dermsquared.com/skin/article/view/1012.